Press "Enter" to skip to content

New patent expiration for Teva Pharms drug SYNRIBO

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Teva Pharms drug SYNRIBO

Annual Drug Patent Expirations for SYNRIBO
Annual Drug Patent Expirations for SYNRIBO

Synribo is a drug marketed by Teva Pharms Intl and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has forty-three patent family members in nineteen countries.

The generic ingredient in SYNRIBO is omacetaxine mepesuccinate. One supplier is listed for this compound. Additional details are available on the omacetaxine mepesuccinate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Teva Pharms drug SYNRIBO
    Do NOT follow this link or you will be banned from the site!